4//SEC Filing
Batycky Alka 4
Accession 0001209191-23-033341
CIK 0001785345other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:21 PM ET
Size
5.4 KB
Accession
0001209191-23-033341
Insider Transaction Report
Form 4
Batycky Alka
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-30+3,600→ 3,600 totalExercise: $3.05Exp: 2033-05-29→ Common Stock (3,600 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the option will vest and become exercisable in 36 equal monthly installments beginning on May 30, 2023, subject to the Reporting Person's continuous service with the Issuer on each such date.
Documents
Issuer
Landos Biopharma, Inc.
CIK 0001785345
Entity typeother
Related Parties
1- filerCIK 0001978041
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 4:21 PM ET
- Size
- 5.4 KB